New Zealand Digestive System Disorder Medicine Sales is set to reach $78.7 Million by 2026 from $73.6 Million, will grow 3% per year. Since 2017, the market grew 3.9% year on year attaining $36,680 Million. Japan, South Korea and Canada respectively were numbers 2, 3 and 4 in this ranking.
How does New Zealand perform in Digestive System Disorder?
Forecast: Alimentary Tract and Metabolism Medicine Sales in New Zealand
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Alimentary Tract and Metabolism Medicine Sales in New Zealand
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Alimentary Tract and Metabolism Medicine Sales in New Zealand
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Alimentary Tract and Metabolism Medicine Sales in New Zealand
- Million New Zealand Dollars
- 2024 to 2028
- ReportLinker Research
Forecast: Alimentary Tract and Metabolism Medicine Sales in New Zealand
- US Dollars PPP Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Average Length of Stay for Diarrhoea and Gastroenteritis of Presumed Infectious Origin in New Zealand
- Days
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Discharges for Diarrhoea and Gastroenteritis Cases of Presumed Infectious Origin in New Zealand
- Units (Hospital Discharges) Per Hundred Thousand Persons
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Discharges for Alcoholic Liver Disease Cases in New Zealand
- Units (Hospital Discharges) Per Hundred Thousand Persons
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Average Length of Stay for Alcoholic Liver Disease Cases in New Zealand
- Days
- 2024 to 2028
- ReportLinker Research